L
Leyre Zubiri
Researcher at Harvard University
Publications - 80
Citations - 3340
Leyre Zubiri is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 13, co-authored 54 publications receiving 1605 citations. Previous affiliations of Leyre Zubiri include University of Navarra.
Papers
More filters
Journal ArticleDOI
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Nicole M. Kuderer,Toni K. Choueiri,Dimpy P. Shah,Yu Shyr,Samuel M. Rubinstein,Donna R. Rivera,Sanjay Shete,Chih-Yuan Hsu,Aakash Desai,Gilberto Lopes,Petros Grivas,Petros Grivas,Corrie A. Painter,Solange Peters,Michael A. Thompson,Ziad Bakouny,Gerald Batist,Tanios Bekaii-Saab,Mehmet Asim Bilen,Nathaniel Bouganim,Mateo Bover Larroya,Daniel Castellano,Salvatore Del Prete,Deborah B. Doroshow,Pamela C Egan,Arielle Elkrief,Dimitrios Farmakiotis,Daniel Blake Flora,Matthew D. Galsky,Michael Glover,Elizabeth A. Griffiths,Anthony P. Gulati,Shilpa Gupta,Navid Hafez,Thorvardur R. Halfdanarson,Jessica Hawley,Emily Hsu,Anup Kasi,Ali Raza Khaki,Ali Raza Khaki,Christopher Lemmon,Colleen Lewis,Barbara Logan,Tyler Masters,Rana R. McKay,Ruben A. Mesa,Alicia K. Morgans,Mary F. Mulcahy,Orestis A. Panagiotou,Prakash Peddi,Nathan A. Pennell,Kerry L. Reynolds,Lane R. Rosen,Rachel P. Rosovsky,Mary Salazar,Andrew Schmidt,Sumit A. Shah,Justin Shaya,John A. Steinharter,Keith Stockerl-Goldstein,Suki Subbiah,Donald C. Vinh,Firas Wehbe,Lisa Weissmann,Julie Tsu Yu Wu,Elizabeth Marie Wulff-Burchfield,Zhuoer Xie,Albert C. Yeh,Albert C. Yeh,Peter Paul Yu,Alice Zhou,Leyre Zubiri,Sanjay Mishra,Gary H. Lyman,Gary H. Lyman,Brian I. Rini,Jeremy L. Warner,Maheen Z. Abidi,Jared D. Acoba,Neeraj Agarwal,Syed A. Ahmad,Archana Ajmera,Jessica K. Altman,Anne H. Angevine,Nilo Azad,Michael H. Bar,Aditya Bardia,Jill S. Barnholtz-Sloan,Briana Barrow,Babar Bashir,Rimma Belenkaya,Stephanie Berg,Eric H. Bernicker,Christine Bestvina,Rohit Bishnoi,Genevieve M. Boland,Mark Bonnen,Gabrielle Bouchard,Daniel W. Bowles,Fiona Busser,Angelo Cabal,Paolo Caimi,Theresa M. Carducci,Carla Casulo,James L. Chen,Jessica M. Clement,David D. Chism,Erin Cook,Catherine Curran,Ahmad Daher,Mark E. Dailey,Saurabh Dahiya,John F. Deeken,George D. Demetri,Sandy DiLullo,Narjust Duma,Rawad Elias,Bryan A. Faller,Leslie A. Fecher,Lawrence E. Feldman,Christopher R. Friese,Paul Fu,Julie Fu,Andy Futreal,Justin F. Gainor,Jorge A. Garcia,David Gill,Erin A. Gillaspie,Antonio Giordano,Grace Glace,Axel Grothey,Shuchi Gulati,Michael J. Gurley,Balazs Halmos,Roy S. Herbst,Dawn L. Hershman,Kent Hoskins,Rohit Jain,Salma K. Jabbour,Alokkumar Jha,Douglas B. Johnson,Monika Joshi,Kaitlin M. Kelleher,Jordan Kharofa,Hina Khan,Jeanna Knoble,Vadim S. Koshkin,Amit Kulkarni,Philip E. Lammers,John C. Leighton,Mark A. Lewis,X. Li,Ang Li,K. M.Steve Lo,Arturo Loaiza-Bonilla,Patricia LoRusso,Clarke A. Low,Maryam B. Lustberg,Daruka Mahadevan,Abdul Hai Mansoor,Michelle Marcum,Merry Jennifer Markham,Catherine Handy Marshall,Sandeep H. Mashru,Sara Matar,Christopher McNair,Shannon K. McWeeney,Janice M. Mehnert,Alvaro G. Menendez,Harry Menon,Marcus Messmer,Ryan Monahan,Sarah Mushtaq,Gayathri Nagaraj,Sarah Nagle,Jarushka Naidoo,John M. Nakayama,Vikram M. Narayan,Heather H. Nelson,Eneida R. Nemecek,Ryan Nguyen,Pier Vitale Nuzzo,Paul E. Oberstein,Adam J. Olszewski,Susie Owenby,Mary M. Pasquinelli,John Philip,Sabitha Prabhakaran,Matthew Puc,Amelie G. Ramirez,Joerg Rathmann,Sanjay G. Revankar,Young Soo Rho,Terence Duane Rhodes,Robert L. Rice,Gregory J. Riely,Jonathan Riess,Cameron Rink,Elizabeth Robilotti,Lori J. Rosenstein,Bertrand Routy,Marc A. Rovito,M. Wasif Saif,Amit Sanyal,Lidia Schapira,Candice Schwartz,Oscar K. Serrano,Mansi R. Shah,Chintan Shah,Grace Shaw,Ardaman Shergill,Geoffrey Shouse,Heloisa P. Soares,Carmen C. Solorzano,Pramod K. Srivastava,Karen Stauffer,Daniel G. Stover,Jamie Stratton,Catherine Stratton,Vivek Subbiah,Rulla M. Tamimi,Nizar M. Tannir,Umit Topaloglu,Eli Van Allen,Susan Van Loon,Karen Vega-Luna,Neeta K. Venepalli,Amit Verma,Praveen Vikas,Sarah Wall,Paul L. Weinstein,Matthias Weiss,Trisha Wise-Draper,William A. Wood,Wenxin Xu,Susan Yackzan,Rosemary Zacks,Tian Zhang,Andrea J. Zimmer,Jack West +239 more
TL;DR: The outcomes of a cohort of patients with cancer and COVID-19 are characterised and potential prognostic factors for mortality and severe illness are identified and race and ethnicity, obesity status, cancer type, type of anticancer therapy, and recent surgery were not associated with mortality.
Journal ArticleDOI
Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
Zsofia D. Drobni,Zsofia D. Drobni,Raza M. Alvi,Jana Taron,Amna Zafar,Sean P. Murphy,Paula K. Rambarat,Rayma C. Mosarla,Charlotte E. Lee,Daniel A. Zlotoff,Vineet K. Raghu,Sarah Hartmann,Hannah K Gilman,Jingyi Gong,Leyre Zubiri,Ryan J. Sullivan,Kerry L. Reynolds,Thomas Mayrhofer,Lili Zhang,Udo Hoffmann,Tomas G. Neilan +20 more
TL;DR: Cardiovascular events were higher after initiation of ICIs, potentially mediated by accelerated progression of atherosclerosis and increased atherosclerotic plaque progression was attenuated with concomitant use of statins or corticosteroids.
Journal ArticleDOI
Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
Miguel F. Sanmamed,Sara Fernández-Landázuri,Carmen P. Rodriguez,Ruth Zarate,Maria D. Lozano,Leyre Zubiri,Jose Luis Perez-Gracia,Salvador Martín-Algarra,Alvaro Gonzalez +8 more
TL;DR: Low concentrations of basal cfBRAF(V600E) were significantly associated with longer overall survival and progression-free survival than higher basal concentrations, and quantification in plasma by ddPCR is useful as a follow-up to treatment response in patients with advanced melanoma.
Journal ArticleDOI
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Petros Grivas,Ali Raza Khaki,Ali Raza Khaki,Trisha Wise-Draper,Benjamin French,C. Hennessy,Chih-Yuan Hsu,Yu Shyr,X. Li,Toni K. Choueiri,Corrie A. Painter,Solange Peters,Brian I. Rini,Michael A. Thompson,Sanjay Mishra,Donna R. Rivera,Jared D. Acoba,Maheen Z. Abidi,Ziad Bakouny,Babar Bashir,T. S. Bekaii-Saab,Stephanie Berg,Eric H. Bernicker,Mehmet Asim Bilen,P. Bindal,Rohit Bishnoi,Nathaniel Bouganim,Daniel W. Bowles,Angelo Cabal,Paolo Caimi,David D. Chism,J. Crowell,Catherine Curran,Aakash Desai,Barry Dixon,Deborah B. Doroshow,Eric B. Durbin,Arielle Elkrief,Dimitrios Farmakiotis,A. Fazio,Leslie A. Fecher,Daniel Blake Flora,Christopher R. Friese,Julie Fu,Shirish M. Gadgeel,Matthew D. Galsky,David Gill,Michael Glover,Sharad Goyal,Punita Grover,Shuchi Gulati,Shilpa Gupta,Susan Halabi,Thorvardur R. Halfdanarson,Balazs Halmos,D. J. Hausrath,Jessica Hawley,Emily Hsu,Minh-Phuong Huynh-Le,Clara Hwang,Chinmay Jani,A. Jayaraj,Douglas B. Johnson,Anup Kasi,Hina Khan,Vadim S. Koshkin,Nicole M. Kuderer,Daniel Kwon,Philip E. Lammers,Ang Li,Arturo Loaiza-Bonilla,Clarke A. Low,Maryam B. Lustberg,Gary H. Lyman,Rana R. McKay,Christopher McNair,Harry Menon,Ruben A. Mesa,V. Mico,D. Mundt,Gayathri Nagaraj,E. S. Nakasone,John M. Nakayama,A. Nizam,N. L. Nock,Cathleen Park,Jaymin M. Patel,Kripa Patel,Prakash Peddi,Nathan A. Pennell,A. J. Piper-Vallillo,Matthew Puc,Deepak Ravindranathan,M. E. Reeves,D. Y. Reuben,Lori J. Rosenstein,Rachel P. Rosovsky,Samuel M. Rubinstein,M. Salazar,Andrew Schmidt,Gary K. Schwartz,Mansi R. Shah,Sumit A. Shah,Chintan Shah,Justin Shaya,Sunny R K Singh,M. Smits,Keith Stockerl-Goldstein,Daniel G. Stover,M. Streckfuss,Suki Subbiah,L. Tachiki,E. Tadesse,Astha Thakkar,Matthew D Tucker,Amit Verma,Donald C. Vinh,Matthias Weiss,Jia Wu,E. Wulff-Burchfield,Zhuoer Xie,Peter Paul Yu,Tian Zhang,Alice Zhou,Huili Zhu,Leyre Zubiri,Dimpy P. Shah,Jeremy L. Warner,Gd L. Lopes +128 more
TL;DR: In this article, the authors analyzed a cohort of patients with cancer and coronavirus 2019 (COVID-19) reported to the COVID19 and Cancer Consortium (CCC19) to identify prognostic clinical factors, including laboratory measurements and anticancer therapies.
Journal ArticleDOI
The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
Harish Seethapathy,Sophia Zhao,Donald F. Chute,Leyre Zubiri,Yaa Oppong,Ian A. Strohbehn,Frank B. Cortazar,David E. Leaf,Meghan J. Mooradian,Alexandra-Chloé Villani,Ryan J. Sullivan,Kerry L. Reynolds,Meghan E. Sise +12 more
TL;DR: AKI is common in patients receiving checkpoint inhibitor therapy and merit thorough evaluation, and the role of PPI and other nephritis-inducing drugs in the development of sustained AKI needs to be better defined.